|
1
|
Peres LC, Cushing-Haugen KL, Anglesio M,
Wicklund K, Bentley R, Berchuck A, Kelemen LE, Nazeran TM, Gilks
CB, Harris HR, et al: Histotype classification of ovarian
carcinoma: A comparison of approaches. Gynecol Oncol. 151:53–60.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kurman RJ, Carcangiu ML, Herrington CS and
Young RH: WHO classification of tumours of female reproductive
organs. (4th). 122014.
|
|
3
|
Bowtell DD, Böhm S, Ahmed AA, Aspuria PJ,
Bast RC Jr, Beral V, Berek JS, Birrer MJ, Blagden S, Bookman MA, et
al: Rethinking ovarian cancer II: Reducing mortality from
high-grade serous ovarian cancer. Nat Rev Cancer. 5:668–679. 2015.
View Article : Google Scholar
|
|
4
|
Wang W, Kryczek I, Dostál L, Lin H, Tan L,
Zhao L, Lu F, Wei S, Maj T, Peng D, et al: Effector T cells
abrogate Stroma-mediated chemoresistance in ovarian cancer. Cell.
165:1092–1105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Binju M, Padilla MA, Singomat T, Kaur P,
Suryo Rahmanto Y, Cohen PA and Yu Y: Mechanisms underlying acquired
platinum resistance in high grade serous ovarian cancer-a mini
review. Biochim Biophys Acta Gen Subj. 1863:371–378. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu W, Wang Q, Yin F, Yang Z, Zhang W,
Gabra H and Li L: Identification of proteomic and metabolic
signatures associated with chemoresistance of human epithelial
ovarian cancer. Int J Oncol. 49:1651–1665. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Augsten M: Cancer-associated fibroblasts
as another polarized cell type of the tumor microenvironment. Front
Oncol. 4:622014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tommelein J, Verset L, Boterberg T,
Demetter P, Bracke M and De Wever O: Cancer-associated fibroblasts
connect metastasis-promoting communication in colorectal cancer.
Front Oncol. 5:632015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schauer IG, Sood AK, Mok S and Liu J:
Cancer-associated fibroblasts and their putative role in
potentiating the initiation and development of epithelial ovarian
cancer. Neoplasia. 13:393–405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Paulsson J and Micke P: Prognostic
relevance of cancer-associated fibroblasts in human cancer. Semin
Cancer Biol. 25:61–68. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jahangiri B, Khalaj-Kondori M, Asadollahi
E and Sadeghizadeh M: Cancer-associated fibroblasts enhance cell
proliferation and metastasis of colorectal cancer SW480 cells by
provoking long noncoding RNA UCA1. J Cell Commun Signal. 13:53–64.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Emon B, Bauer J, Jain Y, Jung B and Saif
T: Biophysics of tumor microenvironment and cancer metastasis-A
mini review. Comput Struct Biotechnol J. 16:279–287. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qin X, Yan M, Wang X, Xu Q, Wang X, Zhu X,
Shi J, Li Z, Zhang J and Chen W: Cancer-associated
fibroblast-derived IL-6 promotes head and neck cancer progression
via the osteopontin-NF-kappa B signaling pathway. Theranostics.
8:921–940. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miki Y, Yashiro M, Okuno T, Kitayama K,
Masuda G, Hirakawa K and Ohira M: CD9-positive exosomes from
cancer-associated fibroblasts stimulate the migration ability of
scirrhous-type gastric cancer cells. Br J Cancer. 118:867–877.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li W, Zhang X, Wang J, Li M, Cao C, Tan J,
Ma D and Gao Q: TGFβ1 in fibroblasts-derived exosomes promotes
epithelial-mesenchymal transition of ovarian cancer cells.
Oncotarget. 8:96035–96047. 2017.PubMed/NCBI
|
|
16
|
Han Y, Zhang Y, Jia T and Sun Y: Molecular
mechanism underlying the tumor-promoting functions of
carcinoma-associated fibroblasts. Tumour Biol. 36:1385–1394. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Österreicher CH, Penz-Österreicher M,
Grivennikov SI, Guma M, Koltsova EK, Datz C, Sasik R, Hardiman G,
Karin M and Brenner DA: Fibroblast-specific protein 1 identifies an
inflammatory subpopulation of macrophages in the liver. Proc Natl
Acad Sci USA. 108:308–313. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Higashino N, Koma YI, Hosono M, Takase N,
Okamoto M, Kodaira H, Nishio M, Shigeoka M, Kakeji Y and Yokozaki
H: Fibroblast activation protein-positive fibroblasts promote tumor
progression through secretion of CCL2 and interleukin-6 in
esophageal squamous cell carcinoma. Lab Invest. 99:777–792. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kratochwil C, Flechsig P, Lindner T,
Abderrahim L, Altmann A, Mier W, Adeberg S, Rathke H, Roehrich M,
Winter H, et al: FAPI-PET/CT: Mean intensity of tracer-uptake (SUV)
in 28 different kinds of cancer. J Nucl Med. April 6–2019.
View Article : Google Scholar
|
|
20
|
Leung CS, Yeung TL, Yip KP, Wong KK, Ho
SY, Mangala LS, Sood AK, Lopez-Berestein G, Sheng J, Wong ST, et
al: Cancer-associated fibroblasts regulate endothelial adhesion
protein LPP to promote ovarian cancer chemoresistance. J Clin
Invest. 128:589–606. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Tang H, Cai J, Zhang T, Guo J,
Feng D and Wang Z: Ovarian cancer-associated fibroblasts contribute
to epithelial ovarian carcinoma metastasis by promoting
angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer
Lett. 303:47–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hosein AN, Wu M, Arcand SL, Lavallée S,
Hébert J, Tonin PN and Basik M: Breast carcinoma-associated
fibroblasts rarely contain p53 mutations or chromosomal
aberrations. Cancer Res. 70:5770–5777. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mao TL, Fan KF and Liu CL: Targeting the
CXCR4/CXCL12 axis in treating epithelial ovarian cancer. Gene Ther.
24:621–629. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dasari S, Fang Y and Mitra AK: Cancer
Associated Fibroblasts: Naughty neighbors that drive ovarian cancer
progression. Cancers (Basel). 10:E4062018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hogen L, Vicus D, Ferguson SE, Gien LT,
Nofech-Mozes S, Lennox GK and Bernardini MQ: Patterns of recurrence
and impact on survival in patients with clear cell ovarian
carcinoma. Int J Gynecol Cancer. 29:1164–1169. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fortner RT, Poole EM, Wentzensen NA,
Trabert B, White E, Arslan AA, Patel AV, Setiawan VW, Visvanathan
K, Weiderpass E, et al: Ovarian cancer risk factors by tumor
aggressiveness: An analysis from the ovarian cancer cohort
consortium. Int J Cancer. 145:58–69. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mitra AK, Zillhardt M, Hua Y, Tiwari P,
Murmann AE, Peter ME and Lengyel E: MicroRNAs reprogram normal
fibroblasts into cancer-associated fibroblasts in ovarian cancer.
Cancer Discov. 2:1100–1108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vafaee F, Colvin EK, Mok SC, Howell VM and
Samimi G: Functional prediction of long non-coding RNAs in ovarian
cancer-associated fibroblasts indicate a potential role in
metastasis. Sci Rep. 7:103742017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Manousopoulou A, Hayden A, Mellone M,
Garay-Baquero DJ, White CH, Noble F, Lopez M, Thomas GJ, Underwood
TJ and Garbis SD: Quantitative proteomic profiling of primary
cancer-associated fibroblasts in oesophageal adenocarcinoma. Br J
Cancer. 118:1200–1207. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ishii G, Ochiai A and Neri S: Phenotypic
and functional heterogeneity of cancer-associated fibroblast within
the tumor microenvironment. Adv Drug Deliv Rev. 99:186–196. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ohlund D, Elyada E and Tuveson D:
Fibroblast heterogeneity in the cancer wound. J Exp Med.
211:1503–1523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Soliman M, Cho EH, Park JG, Kim JY,
Alfajaro MM, Baek YB, Kim DS, Kang MI, Park SI and Cho KO:
Rotavirus-induced early activation of the RhoA/ROCK/MLC signaling
pathway mediates the disruption of tight junctions in polarized
MDCK cells. Sci Rep. 8:139312018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang W, Du H, Liu H, Hu F and Liu G: SMAD
specific E3 ubiquitin protein ligase 1 promotes ovarian cancer cell
migration and invasion via the activation of the RhoA/ROCK
signaling pathway. Oncol Rep. 41:668–676. 2019.PubMed/NCBI
|
|
35
|
Feng S, Zou L, Wang H, He R, Liu K and Zhu
H: RhoA/ROCK-2 pathway inhibition and tight junction protein
upregulation by catalpol suppresses lipopolysaccaride-induced
disruption of blood-brain barrier permeability. Molecules. 23(pii):
E23712018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Inoue Y, Ueda M, Tasaki M, Takeshima A,
Nagatoshi A, Masuda T, Misumi Y, Kosaka T, Nomura T, Mizukami M, et
al: Sushi repeat-containing protein 1: A novel disease-associated
molecule in cerebral amyloid angiopathy. Acta Neuropathol.
134:605–617. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Iragavarapu S, Algeciras ME, Lee RK and
Bhattacharya SK: ETX1 is over-expressed in the glaucomatous
trabecular meshwork. Mol Vis. 15:2061–2067. 2009.PubMed/NCBI
|
|
38
|
Tambe Y, Hasebe M, Kim CJ, Yamamoto A and
Inoue H: The drs tumor suppressor regulates glucose metabolism via
lactate dehydrogenase-B. Mol Carcinog. 55:52–63. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chowdhury A, Hasselbach L, Echtermeyer F,
Jyotsana N, Theilmeier G and Herzog C: Fibulin-6 regulates
pro-fibrotic TGF-β responses in neonatal mouse ventricular cardiac
fibroblasts. Sci Rep. 7:427252017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lan H, Wang X, Jiang L, Wu J, Wan X, Zeng
L, Zhang D, Lin Y, Hou C, Wu S and Tse YC: An extracellular matrix
protein promotes anillin-dependent processes in the
Caenorhabditis elegans germline. Life Sci Alliance. 2(pii):
e2018001522019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xu X and Vogel BE: A secreted protein
promotes cleavage furrow maturation during cytokinesis. Curr Biol.
21:114–119. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pras E, Kristal D, Shoshany N, Volodarsky
D, Vulih I, Celniker G, Isakov O, Shomron N and Pras E: Rare
genetic variants in Tunisian Jewish patients suffering from
age-related macular degeneration. J Med Genet. 52:484–492. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Carney TJ, Feitosa NM, Sonntag C, Slanchev
K, Kluger J, Kiyozumi D, Gebauer JM, Coffin Talbot J, Kimmel CB,
Sekiguchi K, et al: Genetic analysis of fin development in
zebrafish identifies furin and hemicentin1 as potential novel
fraser syndrome disease genes. PLoS Genet. 6:e10009072010.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Toffoli B, Zennaro C, Winkler C, Giordano
Attianese GMP, Bernardi S, Carraro M, Gilardi F and Desvergne B:
Hemicentin 1 influences podocyte dynamic changes in glomerular
diseases. Am J Physiol Renal Physiol. 314:F1154–F1165. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen JS, Liang LL, Xu HX, Chen F, Shen SL,
Chen W, Chen LZ, Su Q, Zhang LJ, Bi J, et al: miR-338-3p inhibits
epithelial-mesenchymal transition and metastasis in hepatocellular
carcinoma cells. Oncotarget. 8:71418–71429. 2016.PubMed/NCBI
|
|
46
|
Xing F, Saidou J and Watabe K: Cancer
associated fibroblasts (CAFs) in tumor microenvironment. Front
Biosci (Landmark Ed). 15:166–179. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hanahan D and Coussens LM: Accessories to
the crime: Functions of cells recruited to the tumor
microenvironment. Cancer Cell. 21:309–322. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhu X, Wang K, Zhang K, Xu F, Yin Y, Zhu L
and Zhou F: Galectin-1 knockdown in carcinoma-associated
fibroblasts inhibits migration and invasion of human MDA-MB-231
breast cancer cells by modulating MMP-9 expression. Acta Biochim
Biophys Sin (Shanghai). 48:462–467. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Labernadie A, Kato T, Brugués A,
Serra-Picamal X, Derzsi S, Arwert E, Weston A, González-Tarragó V,
Elosegui-Artola A, Albertazzi L, et al: A mechanically active
heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to
drive cancer cell invasion. Nat Cell Biol. 19:224–237. 2017.
View Article : Google Scholar : PubMed/NCBI
|
